OSI Brushes Off Hostile Bid, Cancer Stocks Surge
OSI Pharmaceuticals soared by over 50% on Monday after receiving an unsolicited buyout bid from Astellas Pharma worth $52 per share.

Read more on Indie Research via Yahoo! Finance